Viewing Study NCT02592018


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2026-06-07 @ 2:38 AM
Study NCT ID: NCT02592018
Status: COMPLETED
Last Update Posted: 2020-09-16
First Post: 2015-10-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunologic Response to Secukinumab in Plaque Psoriasis
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords: